HIVClinicalForum
Meeting category
Date(s)
30 Jun 2020 - 1 Jul 2020
EACCME Credits
8
Organizer

Global HIV Clinical Forum 2020

Related Enduring Materials

Enduring Materials
Program

Day 1 - Thursday, 30 June 2020

- 18:00
18:00 CEST
Welcome, Introductions, and Goals: Guidance on Using Online Format and Online Needs Assessment
Session 1: State-Of-The Art Lectures: Update on Clinical Trials and Their Significance for Patient Management. -
Session Chair
Daniel Kuritzkes, MD
Brigham and Women's Hospital / Harvard Medical School, United States
18:05 CEST
Keynote Lecture: Update on COVID-19 in HIV Infected Patients
Daniel Kuritzkes, MD
Brigham and Women's Hospital / Harvard Medical School, United States
18:25 CEST
Clinical Update: First-Line Therapies
David Wohl, MD
UNC School of Medicine, United States
18:45 CEST
Clinical Update: Injectable Drug Regimens
Martin Markowitz, MD
Rockefeller University, United States
19:05 CEST
Clinical Update: Highly Treatment-Experienced Patients
Michael Kozal, MD
Stanford University School of Medicine, United States
19:25 CEST
Roundtable Discussion and Q/A With Speakers From Session 1
Session 2: Reduced Drug Regimens: Scientific Considerations -
Session Chair
Sharon Walmsley, CM, MD, FRCPC
University Health Network, Canada
19:55 CEST
Implications for Resistance
Shafer, Robert
Robert Shafer, MD
Stanford University Medical Center, Stanford, CA, USA
20:15 CEST
Implications for Sanctuary Sites and Drug Interactions
Marta Boffito, MD, PhD, FRCP, MBA
Chelsea and Westminster Hospital NHS Foundation Trust; Imperial College London; United Kingdom
20:35 CEST
Implications for Women's Health
Sharon Walmsley, CM, MD, FRCPC
University Health Network, Canada
20:55 CEST
Clinical Case: Reduced Drug Therapy
Montgomery, Mary
Mary Montgomery, MD
Brigham and Women's Hospital/Harvard Medical School, Boston, MA, USA
21:10 CEST
Roundtable Discussion and Q/A With Speakers From Session 2
21:30 CEST
End of Day 1

Day 2 - Wednesday, 1 July 2020

- 18:00
18:00 CEST
Welcome, Introductions, and Goals: Guidance on Using Online Format and Online Needs Assessment
Jonathan Schapiro, MD
National Hemophilia Center, Sheba Medical Center, Israel
Session 3: Optimizing Clinical Implementation of Long-Acting Therapies -
Session Chair
Anton Pozniak, MD, FRCP
Chelsea and Westminster Hospital, United Kingdom
18:05 CEST
How and When to Monitor patients on LAs?
Monica Gandhi, MD, MPH
University of California San Francisco, United States
18:25 CEST
Strategies for Management of Drug-Drug Interactions With Long-Acting Therapies
David Back, PhD
University of Liverpool, United Kingdom
18:45 CEST
Introducing New Therapies in Middle-Income Countries
Pedro Cahn, MD, PhD
Fundación Huésped Buenos Aires, Argentina
19:05 CEST
Starting Long-Acting Drugs in the COVID-19 Era
Anton Pozniak, MD, FRCP
Chelsea and Westminster Hospital, United Kingdom
19:25 CEST
Roundtable Discussion and Q/A With Speakers From Session 3
Session 4: HIV Prevention and Cure -
Session Chair
Jonathan Schapiro, MD
National Hemophilia Center, Sheba Medical Center, Israel
19:55 CEST
Update on HIV Cure
Steven Deeks, MD
University of California, San Francisco, United States
20:15 CEST
HIV Vaccines - Where Are We?
Linda-Gail Bekker, MBChB, DTMH, DCH, FCP(SA), PhD
Desmond Tutu Health Foundation / University of Cape Town (UCT), South Africa
20:35 CEST
Oral versus Injectable PrEP
Richard Elion, MD
Washington Health Institute, United States
20:55 CEST
Clinical Case: Potential Challenges of Drug Interactions of Long-Acting Agents
Catia Marzolini, PharmD, PhD
University Hospital of Basel, University Hospital of Lausanne, Switzerland; University of Liverpool, United Kingdom
21:10 CEST
Roundtable Discussion and Q/A With Speakers From Session 4
21:30 CEST
Summary and Closure of Program
Jonathan Schapiro, MD
National Hemophilia Center, Sheba Medical Center, Israel
21:35 CEST
End of Day 2
Overview
Welcome

The Global HIV Clinical Forum 2020: Optimizing Treatment was held as a virtual meeting from 30 June - 31 July 2020. 

The Forum meeting provided challenging plenary lectures followed by ample time for roundtable discussions, Q&A with all session speakers, and stimulating interaction in order to bridge the knowledge gap between experts and the HIV-treating community globally. This forum meeting was a 2-day program that was live-streamed globally.

The HIV Clinical Forum is a series of interactive programs that provide an independent scientific program on emerging topics in HIV involving experts where HIV clinicians and allied healthcare professionals receive updates on the latest developments related to HIV management, where they can share their clinical experience and present the results from their ongoing and completed cohorts/ research programs.

The Global HIV Clinical Forum: Optimizing Treatment was initiated in 2016 by the Program Directors: Dr. Jonathan Schapiro and Dr. Charles Boucher. The aim of the forum meeting is to provide clinical education to the junior Healthcare Professionals by inviting international key experts to give their perspective on relevant clinical topics related to the management of PLWH.

Program Chairs 2020

General Information 

Meeting Objectives
With the HIV Clinical Forum program we aim to:

- Build a community of healthcare professionals devoted to providing optimal clinical care for their patients

- Create a platform for interactive information exchange on novel treatment options

- Translate the latest research achievements into clinical guidance for the optimal management of individuals living with HIV
Learning Objectives
After participating in the HIV Clinical Forum, participants will be able to:

- Understand the clinical data supporting novel treatment strategies

- Describe the pros and cons of novel treatment strategies

- Understand how to integrate novel treatment strategies into routine patient care

- Be knowledgeable of the clinical data supporting long-acting injectable regimens

- Identify patients who might best benefit from long acting injectable regimens

- Know how best to integrate injectable drugs in to routine clinical care

- Improve their skills in defining and identifying complex HIV patients

- Stay informed on new drug options for complex patients

- Understand how best to use new treatment options in complex HIV patients

Practical Information 

CME Accreditation
The Global HIV Clinical Forum 2020 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 8 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Certificate of Attendance
A certificate of attendance was sent to individuals that successfully completed the program and post-meeting survey.
Disclaimer
This forum is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this forum. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the forum.
Committee
Program Chairs

The Program Chairs are selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the forum, identify interesting topics and candidate speakers, and review all submitted abstracts.

Support

The Global HIV Clinical Forum 2020 is supported by an independent educational grant from ViiV Healthcare.

​ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.